GOLDMAN SACHS GROUP INC - ANAVEX LIFE SCIENCES CORP ownership

ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 93 filers reported holding ANAVEX LIFE SCIENCES CORP in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ANAVEX LIFE SCIENCES CORP
ValueSharesWeighting
Q3 2023$1,447,661
-44.4%
221,017
-31.0%
0.00%
-100.0%
Q2 2023$2,603,226
-67.1%
320,200
-65.4%
0.00%0.0%
Q1 2023$7,921,354
-9.4%
924,312
-2.1%
0.00%
-50.0%
Q4 2022$8,745,190
+173.9%
944,405
+205.3%
0.00%
+100.0%
Q3 2022$3,193,000
-10.9%
309,313
-13.6%
0.00%0.0%
Q2 2022$3,583,000
-33.7%
357,860
-18.4%
0.00%0.0%
Q1 2022$5,402,000
-18.1%
438,764
+15.3%
0.00%0.0%
Q4 2021$6,597,000
+241.3%
380,465
+253.3%
0.00%
Q3 2021$1,933,000
-6.2%
107,674
+19.5%
0.00%
Q2 2021$2,060,000
+1.4%
90,117
-33.7%
0.00%
-100.0%
Q1 2021$2,031,000
+991.9%
135,872
+294.8%
0.00%
Q4 2020$186,000
+69.1%
34,415
+42.8%
0.00%
Q3 2020$110,000
+3.8%
24,098
+12.2%
0.00%
Q2 2020$106,000
-18.5%
21,487
-48.1%
0.00%
Q1 2020$130,000
-59.0%
41,376
-64.3%
0.00%
Q3 2018$317,000
-61.9%
115,954
-63.6%
0.00%
Q2 2018$833,000
+758.8%
318,271
+806.1%
0.00%
Q1 2018$97,000
+136.6%
35,126
+238.3%
0.00%
Q4 2016$41,000
-36.9%
10,384
-42.1%
0.00%
Q3 2016$65,000
-53.9%
17,927
-22.2%
0.00%
Q2 2016$141,000
-48.5%
23,051
-58.8%
0.00%
Q1 2016$274,00055,9400.00%
Other shareholders
ANAVEX LIFE SCIENCES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 942,500$9,727,0003.29%
Pier Capital, LLC 384,811$3,971,0000.68%
AllSquare Wealth Management LLC 65,956$681,0000.49%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$1,032,0000.35%
Royal Capital Wealth Management, LLC 18,500$191,0000.22%
Bridgefront Capital, LLC 10,214$105,0000.11%
Hikari Power Ltd 85,585$883,0000.10%
Orion Capital Management LLC 9,500$98,0000.08%
OCCUDO QUANTITATIVE STRATEGIES LP 86,158$889,0000.07%
Hennion & Walsh Asset Management, Inc. 66,459$686,0000.04%
View complete list of ANAVEX LIFE SCIENCES CORP shareholders